Sotio picks up rights to cancer metabolism program

Sotio a.s. (Prague, Czech Republic) gained exclusive rights to an oncology program in tumor metabolism from Lead Discovery Center GmbH (Dortmund, Germany) and Max Planck Innovation GmbH (Munich, Germany). The target was not disclosed, nor were financial terms.

LDC and its academic partners are to perform lead optimization, and Sotio will be responsible for preclinical and clinical development, marketing and commercialization. LDC is eligible for research funding, milestones and royalties...